Accomplished industry leader Robert J. Dempsey brings extensive commercialization and ophthalmic expertise Gary S. Jacob, Ph.D., will transition to Chief Development Officer and continue to serve on ...

Accomplished industry leader Robert J. Dempsey brings extensive commercialization and ophthalmic expertise Gary S. Jacob, Ph.D., will transition to Chief Development Officer and continue to serve on ...

Please provide your email address to receive an email when new articles are posted on . Dempsey has more than 20 years of experience in global ophthalmology. The move will support Okyo’s strategic ...

OKYO Pharma Limited Sponsored ADR ( (OKYO)) has issued an update. On January 5, 2026, OKYO Pharma appointed ophthalmology industry veteran Robert J. Dempsey as Chief Executive Officer and an executive ...

Gary S. Jacob, Ph.D., will transition to Chief Development Officer and continue to serve on the Board LONDON and NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a ...

The English language is full of words that seem overstuffed with unnecessary letters, feel like they should be spelled a different way, or just don't make sense. Here are some of our favorites, ...

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and ...